Health News Editor

Onward Medical, led by CEO Dave Marver, is placing a significant focus on neurostimulation as a means to enhance the quality of life for individuals dealing with paralysis. Marver expressed optimism following recent clinical...

UnitedHealth Group managers were really pushing their doctors to see more patients and hit their targets, according to emails obtained in late 2020. Despite the surge in Covid-19 cases and the lack of a...

Today, I came across an interesting research letter published in JAMA Network Open that sheds light on how healthcare professionals perceive the use of large language models, such as AI chatbots, in patient communication....

In the early days of the Covid-19 pandemic, hospitals were in urgent need of solutions to handle the influx of severely ill patients. Many hospitals, including those in Yale's health system, turned to an...

Welcome, readers! Today, we have some interesting updates from the world of healthcare. UnitedHealthcare, a major insurance provider, has implemented new prior authorization rules for Medicare Advantage members seeking physical, occupational, and speech therapy....

It’s a warm afternoon in Bozeman, and Jackie Johnston, a dedicated Democrat, is knocking on doors to discuss abortion rights in Montana. Her advocacy for protecting abortion rights is personal, driven by her daughter’s...

The Broad Institute of MIT and Harvard, known for its groundbreaking biotech research, recently made the decision to lay off 87 employees. This move comes as the institute undergoes some restructuring within its teams....

Jasper Therapeutics, a biotech company focusing on improving stem cell transplants and treating immune-mediated diseases, shared positive results from an initial clinical trial of its experimental drug for a chronic skin condition. The drug,...

Biotech investors have been showing a lot of interest in the field of autoimmune diseases this year. While the obesity market is also attracting attention, autoimmune conditions have been at the forefront of drug...

SalioGen Therapeutics, a biotech company that secured $135 million in funding to develop a cutting-edge gene-editing technology, is facing a challenging situation as it recently laid off a significant number of employees and adjusted...

Imagine a world where your elderly mother could receive quality care at home without bankrupting your family. Now picture that same world, but with a twist: The caregiver isn’t a typical home care worker,...

First Opinion is STAT’s platform for interesting, illuminating, and provocative articles about the life sciences writ large, written by biotech insiders, health care workers, researchers, and others.“To encourage robust, good-faith discussion about issues raised...